Trial Profile
Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia: a Multicenter Clinical Trial
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 Mar 2018
Price :
$35
*
At a glance
- Drugs Thrombopoietin (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 18 Apr 2016 Planned End Date changed from 1 Aug 2015 to 1 Aug 2017.
- 18 Apr 2016 Planned primary completion date changed from 1 Jun 2015 to 1 Jun 2017.
- 25 Sep 2014 New trial record